After many years of clinical practice and research the well-known and widely respected Dr. Pierre Maison Blanche, member of the famous cardiology units of the Lariboisiere and Bichat Hospitals in Paris, has accumulated and annotated a vast amount of continuous recording ECG data (aka Holter) and has decided to make it available through a partnership with AMPS.
The database, which will be constantly updated with new data, consists to date of over 1000 annotated and anonymized continuous ECG recordings that can be used by manufacturers and software developing companies seeking to test the reliability of their equipment and algorithms before commercialization.
The raw ECG waveform data was acquired using Spiderview Holter recorder devices (Sorin Group), with a sampling rate of 200 Hz and an amplitude resolution of 10 uV. The vast majority of data is 2-lead recordings. Few 3 and 12-leads recordings are also present.
All Holter ECG recordings have been automatically annotated using CER-S (AMPS llc, NY, US) for both the beat detection and rhythm analysis, i.e. Arrhythmias.
All events, both rhythm and beat annotations, have been then manually reviewed and adjusted by the Cardiologist Dr. Pierre Maison-Blanche* using CER-S (AMPS llc, NY, US).
An Holter recording was considered eligible for database enrollment only if the maximum noise level was 1 minute/hour, except for the beginning and end of the recording.
Dr. Maison-Blanche earned his MD in 1981 from the University of Paris and specialized in Cardiology at Lariboisire Hospital. For the past thirty years, Dr. Maison-Blanche has performed angiography and clinical research in the cardiovascular therapeutic area in the Cardiology Department at Lariboisiere Hospital. Dr. Maison-Blanche's clinical specialty is non-invasive cardiac electrophysiology and he organized the first ECG Laboratory at Lariboisiere Hospital under the leadership of Dr. Philippe Coumel.
Dr. Maison-Blanche serves as a Consultant for Assistance Publique des Hopitaux de Paris. In 1998, Maison-Blanche established the Centralized ECG Services Department for MDS Pharma Services in Paris, France and chaired the MDS ECG Advisory Board from 2002 - 2006. Maison-Blanche has participated in several End of Phase II meetings with the Food and Drug Administration (FDA) as well as in Advisory Boards as an active member. He is currently a member and the Chairman of Data Monitoring Committees for on going trials.
Dr. Maison-Blanche is a highly sought after speaker and has published with leading journals around the world. He is a member of numerous professional societies and boards including the International Society for Holter and Noninvasive Electrocardiology.